Table 1 Baseline characteristics of patients with MG who underwent kidney biopsy.
Clinical indices | MGUS Lesions (nā=ā231) | MGRS Lesions (nā=ā116) | p value |
|---|---|---|---|
Male, n (%) | 78 (33.8) | 39 (33.6) | 1 |
Age, years | 55.13 (12.73) | 60.18 (9.22) | ā<ā0.001 |
Edema, n (%) | 180 (77.9) | 86 (74.1) | 0.537 |
Nausea, n (%) | 46 (19.9) | 40 (34.5) | 0.01 |
Hypertension, n (%) | 126 (54.5) | 47 (40.5) | 0.034 |
Hematuria | 113 (48.9) | 30 (25.9) | ā<ā0.001 |
Hemoglobin (g/L) | 117.20 (22.76) | 118.18 (25.67) | 0.717 |
BUN (mmol/L) | 12.39 (21.89) | 9.37 (7.18) | 0.15 |
Creatinine (μmol/L) | 152.32 (142.43) | 150.49 (164.71) | 0.915 |
UA (μmol/L) | 365.95 (123.72) | 365.60 (196.61) | 0.984 |
Albumin (g/L) | 29.57 (8.72) | 27.81 (8.67) | 0.076 |
eGFR (mL/min per 1.73 m2) | 68.66 (72.89) | 67.84 (84.29) | 0.161 |
24hTP (g/day) | 4.60 (4.15) | 5.52 (3.62) | 0.043 |
CRP (mmol/L) | 12.18 (29.80) | 5.98 (10.71) | 0.035 |
ESR (mm/h) | 46.55 (36.70) | 50.61 (35.49) | 0.343 |
Complement 3 (g/L) | 1.11 (0.29) | 1.16 (0.31) | 0.173 |
Complement 4 (g/L) | 0.28 (0.12) | 0.31 (0.14) | 0.087 |
Abnormal FLC ratio | 38 (16.5) | 87 (75.0) | ā<ā0.001 |
dFLC (mg/L) | 62.13 (320.37) | 874.79 (2220.76) | ā<ā0.001 |